| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Technical Officer
1 company
Clark Eliana is an EVP, Chief Technical Officer at Intellia Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Technical Officer | Sell | 9,515 | $9.21 | $87,633.15 | -9.8% | +41.9% | - | |
| Jul 1, 2025 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Technical Officer | Sell | 1,022 | $9.82 | $10,036.04 | -1.1% | +71.3% | - | |
| Mar 4, 2025 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Technical Officer | Sell | 679 | $8.99 | $6,104.21 | -0.7% | -21.3% | +52.0% | |
| Jan 3, 2025 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Technical Officer | Sell | 7,978 | $12.17 | $97,088.64 | -5.6% | -43.2% | -24.1% | |
| Jul 1, 2024 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Technical Officer | Sell | 405 | $22.93 | $9,286.65 | -0.6% | -8.5% | -56.0% | |
| Mar 4, 2024 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Technical Officer | Sell | 605 | $32.99 | $19,958.95 | -0.8% | -27.4% | -71.9% | |
| Jan 3, 2024 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Technical Officer | Sell | 4,608 | $29.50 | $135,954.30 | -5.1% | -14.9% | -58.6% | |
| Jul 3, 2023 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Technical Officer | Sell | 360 | $40.51 | $14,583.60 | -0.8% | -27.8% | -45.6% | |
| Jun 20, 2023 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Technical Officer | Sale+OE | 5,000 | $45.00 | $225,000.00 | -10.0% | -19.7% | -44.6% | |
| Jan 4, 2023 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Technical Officer | Sell | 2,028 | $37.65 | $76,356.90 | -4.2% | -7.5% | -24.6% |